Pfizer is suing to stop Novo Nordisk from throwing a wrench in its acquisition of Metsera, the next-gen obesity biotech that Pfizer said it would buy for …
UNC6384 Targets European Diplomatic Entities With Windows Exploit
The spear-phishing campaign uses fake European Commission and NATO-themed lures to trick diplomatic personnel into clicking malicious links.
Ribbon Communications Breach Marks Latest Telecom Attack
The US telecom company disclosed that suspected nation-state actors first gained access to its network in December of last year, though it’s unclear if attackers obtained sensitive data.
Here’s the latest company planning for gene-edited babies
A West Coast biotech entrepreneur says he’s secured $30 million to form a public-benefit company to study how to safely create genetically edited babies, marking the largest known investment into the taboo technology. The new company, called Preventive, is being formed to research so-called “heritable genome editing,” in which the DNA of embryos would be […]
Hawaii federal judge rules against FDA decision to maintain abortion pill restrictions
A Biden-era FDA decision to keep certain restrictions in place for the abortion pill mifepristone was arbitrary and unlawful, a federal judge in Hawaii ruled. The ruling marks the latest development in a long-running legal …
Baby KJ researchers publish FDA interactions as agency eyes new pathway
Academics and biotechs looking at bespoke gene therapies like the one used to treat baby KJ Muldoon now have a trove of new information for navigating a unique FDA approval process. …
FDA commissioner says more ‘deregulatory’ action coming soon
FDA Commissioner Marty Makary twice this week hinted that the agency will soon take more “deregulatory” action, in addition to the FDA’s recent move to relax biosimilar clinical trial requirements. In a press conference on …
Drugmakers are having frequent ‘most favored nation’ talks with White House
The Trump administration’s negotiations with large pharma companies are making gradual progress, according to top drugmaker CEOs, though none suggested that a new deal was imminent. On quarterly earnings calls in recent days, executives from …
Government Approach to Disrupt Cyber Scams is ‘Fragmented’
Users contend with cybersecurity scams throughout their day; a new Cyber Civic Engagement program wants to provide them with the skills to fight back.
Why are BridgeBio and Alnylam both seeing strong growth for their heart drugs?
The much-ballyhooed competition between BridgeBio and Alnylam has been less of a tug-of-war and more of a rising-tide-lifts-all-boats scenario. That’s because both companies are hitting the milestones they each laid out for the respective launches …